🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 95075A107
- Market Cap
- Small Cap
- IPO
- 4/30/2021 · $16.00/share
Business: Werewolf Therapeutics, Inc. is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The Company is leveraging its proprietary PREDATOR™ platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies.
Company Contact
- CEO
- Dan Hicklin
- CFO
- Timothy W. Trost
- Headquarters
- 200 Talcott Ave, 2nd Floor, Watertown, MA 02472
- Phone
- 617-952-0555
- Investor Relations
- Alan Lada, Solebury Trout · 617-221-8006 · IR@werewolftx.com